BlackRock, Inc. 13D and 13G filings for Vanda Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-07 1:40 pm Sale | 2025-01-31 | 13G | Vanda Pharmaceuticals Inc. VNDA | BlackRock Inc. BLK | 4,699,280 8.100% | -4,404,924 (-48.38%) | Filing |
| 2025-02-05 1:23 pm Purchase | 2024-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA | BlackRock Inc. BLK | 9,104,204 15.600% | 757,837 (+9.08%) | Filing |
| 2024-01-23 11:52 am Purchase | 2023-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA | BlackRock Inc. BLK | 8,346,367 14.500% | 1,587,250 (+23.48%) | Filing |
| 2023-10-06 2:34 pm Sale | 2023-09-30 | 13G | Vanda Pharmaceuticals Inc. VNDA | BlackRock Inc. BLK | 6,759,117 11.800% | -3,567,497 (-34.55%) | Filing |
| 2023-01-24 1:56 pm Purchase | 2022-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA | BlackRock Inc. BLK | 10,326,614 18.200% | 501,239 (+5.10%) | Filing |
| 2022-01-27 5:14 pm Unchanged | 2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA | BlackRock Inc. BLK | 9,825,375 17.600% | 0 (Unchanged) | Filing |
| 2022-01-26 09:17 am Purchase | 2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA | BlackRock Inc. BLK | 9,825,375 17.600% | 10,778 (+0.11%) | Filing |
| 2021-01-25 4:49 pm Purchase | 2020-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA | BlackRock Inc. BLK | 9,814,597 17.900% | 428,716 (+4.57%) | Filing |